The Autoimmune Registry hosts a monthly webinar to bring together patient advocacy groups related to autoimmune diseases. For this month, we invited Dave Walton, CEO of T1D Exchange, who will discuss how T1D Exchange partners with leading life sciences companies and endocrinology centers around the US to accelerate product development and operationalize meaningful innovation in the real world. The webinar will include a high-level overview of T1D Exchange and its core programs—including its Quality Improvement Collaborative, Patient Registry and Online Community impacting over 150,000 T1Ds—showcasing how it focuses on driving change to benefit those living with diabetes and their caregivers.